Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer

NCT00696007 is an interventional clinical trial that is for Transitional Cell Carcinoma conditions and was started in April of 2008. This trial has 120 people enrolled who are within the adult and senior age range. This trial is funded by an outside organization. The specific sponsors / contributors of this trial are as follows: Lahey Clinic. The following interventions were used in this trial: (drug) Gemcitabine and cisplatin, and (other) Retrospective comparison. This trial is reported / scheduled to have been completed in April of 2019.